Changes / RenewalRSSAbout RSS
- June 24, 2024 Release JT Receives Manufacturing and Marketing Approval of VTAMA® Cream 1% for the Treatment of Atopic Dermatitis and Plaque Psoriasis in Japan(PDF)
- May 31, 2024 Release Positive Top-line Results of Phase 3 Clinical Study (Comparative Study) of JTE-061 (tapinarof) Cream, Aryl hydrocarbon Receptor (AhR) agonist, in Pediatric Patients with Atopic Dermatitis in Japan(PDF)
- April 26, 2024 Information " Financial Results " was updated.
- March 26, 2024 Information " Creating Supportive Workplaces " was updated.
- March 15, 2024 Release Torii’s Views on Report from ISS, a Proxy Advisory Firm, On Proposals for Torii’s General Meeting of Shareholders(PDF)